GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SARS-cov-2 nucleocapsid protein C-terminal RNA binding domain at 2.0A resolution

Analyse Crystal structure of SARS-cov-2 nucleocapsid protein C-terminal RNA binding… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7F2B
Type
protein
Length
212 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nucleoprotein
UniProt
P0DTC9
Ligands
PO4, CL
Pockets
2 · best druggability 0.43

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
B, ANucleoproteinprotein10641% helix, 21% strandP0DTC9

Ligands and binding sites

  • PO4 · Phosphate ion · ion · 6 copies · chains B, A
  • CL · Chloride ion · ion · chains B, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1970.430.7821empty
2760.340.7522empty

Interfaces

1 interface between chains.

  • B–A · 2574 Ų buried · 44 hydrogen bonds · protein-protein

Compared structures

  • 7F2B · Crystal structure of SARS-CoV-2 nucleocapsid protein C-terminal RNA binding domain at… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.